Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
DiagnaMed Expands with Drug and Clinical Research AI Platform
Leveraging proprietary EEG data from previous and future research studies with BRAIN AGE® Brain Health AI Accelerating clinical trial development and discovering potential novel treatments for neurological, psychiatric and infectious diseases TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, announces it is expanding the use of its novel BRAIN AGE® Brain Health AI Platform (“BRAIN AGE®”) through leveraging its electroencephalograph (“EEG”) data from research studies and future data collection, and applying it to build a potential drug discovery and clinical research AI platform. EEG provides a real-time readout of brain-wave activity in different brain regions and can measure a drug effect on the brain.» Mehr auf globenewswire.com
Bitcoin dominance surges as crypto markets show signs of consolidation
Bitcoin (BCT) traders had nothing to write home about over the weekend trading session. The world’s largest cryptocurrency stayed flat against the US dollar on Saturday before falling around one percentage point on Sunday. Things were livelier this morning, with the BTC/USD pair recouping all of yesterday’s losses. At the time of writing, the pair was swapping for $66,274, roughly 9.2% higher week on week. Bitcoin remains 59% higher week on week – Source: tradingview.com The cryptocurrency markets are showing signs of consolidation. Bitcoin dominance, which is a measure of bitcoin’s share of the entire cryptocurrency markets, has increased from 46% this time last year to more than 54% today. It suggests a lack of risk appetite for more volatile, less liquid altcoins despite recent noise surrounding meme coins. Source: coinmarketcap.com Ethereum (ETH)’s share of the market has dropped off considerably- from 19.6% to just 15.4%. The ETH/USD pair is currently swapping for $3,100, or around 4.2% higher week on week. In the broader altcoin space, Solana (SOL) has reared ahead with a 22% weekly gain, while Ripple (XRP), Dogecoin (DOGE) and Cardano (ADA) have added low to mid single digits. Global cryptocurrency market capitalisation currently stands at $2.42 trillion. Alligator Energy Ltd (ASX:AGE, OTC:ALGEF) CEO Greg Hall is back in the Proactive studio after the company began drilling at the Big Lake Uranium Project in South Australia’s Cooper Basin. Wallis Drilling has been contracted to complete up to 40 aircore holes on cross-sectional lines, with holes spaced 50-200 metres apart and averaging 150 metres in depth. AGE’s inaugural program aims to pinpoint northern extensions to the Namba, Eyre and Winton sedimentary formations, which also host prominent Beverley, Four Mile and Honeymoon ISR uranium operations in South Australia. Historical drilling around 16 years ago indicated uranium presence in thin bands and Hall is confident that the project shares characteristics with other global hydrocarbon-related in-situ recovery (ISR) uranium fields. Speaking with Proactive’s Elisha Newell, Hall said he was pleased to get the program underway, thanking traditional landowners and stakeholders for their role in the campaign’s commencement. While it’s still early days, the MD believes the project shows potential to follow the Kazakhstan uranium-bearing basin model. Ultimately, results from the program — expected in August or September — will guide more targeted drilling efforts later in 2024 or early 2025.» Mehr auf proactiveinvestors.com
QVC DEFINES A NEW AGE OF POSSIBILITY CHAMPIONING WOMEN 50 AND OVER TO LIVE THEIR BEST LIVES
The shopping entertainment destination introduces its first-ever Quintessential 50 (Q50) comprised of 50 authentic and inspiring female celebrities, activists, business leaders and lifestyle experts who exemplify the possibilities of life over 50. Members of the Q50 include Christina Applegate, Patti LaBelle, Rita Wilson, Naomi Watts, Martha Stewart, Queen Latifah and many more; Age of Possibility campaign to kick off April 24 with Summit in Las Vegas.» Mehr auf prnewswire.com
Historische Dividenden
Alle DividendenKennzahlenUnternehmenszahlen
(EUR) | März 2024 | |
---|---|---|
Umsatz | 4,63k | - |
Bruttoeinkommen | 4,63k | - |
Nettoeinkommen | −8,74 Mio | - |
EBITDA | −2,15 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 26,50 Mio€ |
Anzahl Aktien | 2,50 Mio |
52 Wochen-Hoch/Tief | 33,58€ - 10,41€ |
Dividenden | Nein |
Beta | 1,19 |
KGV (PE Ratio) | −1,48 |
KGWV (PEG Ratio) | −0,14 |
KBV (PB Ratio) | −7,19 |
KUV (PS Ratio) | 239,30 |
Unternehmensprofil
AgeX Therapeutics, Inc. ist ein Biotechnologieunternehmen, das sich auf die Entwicklung und Vermarktung neuartiger Therapeutika zur Behandlung von altersbedingten und degenerativen Erkrankungen in den Vereinigten Staaten konzentriert. Zu den führenden zellbasierten therapeutischen Kandidaten des Unternehmens in der Entwicklung gehören AGEX-BAT1, ein zelltherapeutischer Produktkandidat für die Behandlung verschiedener altersbedingter Stoffwechselstörungen wie Typ-II-Diabetes bei Erwachsenen und Fettleibigkeit, und AGEX-VASC1, eine zellbasierte Therapie zur Wiederherstellung der Gefäßversorgung in gealterten ischämischen Geweben, wie z. B. bei peripheren Gefäßerkrankungen und ischämischen Herzerkrankungen. Der führende arzneimittelbasierte therapeutische Kandidat für die narbenlose Wundheilung ist AGEX-iTR1547, eine arzneimittelbasierte Formulierung; und der führende biologische Kandidat für die induzierte Geweberegeneration ist AGEX-iTR1550, eine Gentransfertechnologie. Das Unternehmen unterhält eine Forschungskooperation mit der University of California in Irvine zur Entwicklung von Zelltherapien zur Behandlung neurologischer Störungen und Krankheiten. AgeX Therapeutics, Inc. wurde im Jahr 2017 gegründet und hat seinen Sitz in Alameda, Kalifornien.
Name | AgeX Therapeutics |
CEO | Eun-Jae Park CPA |
Sitz | Alameda, ca USA |
Website | |
Industrie | Chemikalien |
Börsengang | 11.11.2016 |
Mitarbeiter | 4 |
Ticker Symbole
Börse | Symbol |
---|---|
AMEX | AGE |
Assets entdecken
Shareholder von AgeX Therapeutics investieren auch in folgende Assets